Citation Tools
PDFImmune cell therapies and immune cell engineering
Original research
Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China